Supporting Figure 1 : Density of technical replicate differences among the triplicate replicates of each of the TOCPA PRM analyses of the ten biomarker proteins in sera from six ovarian cancer (red) and seven control patients (black).
) from three technical replicate PRM analyses of the ten biomarkers in the TOPCA assay. As indicated by the red arrowhead line in the Apolipoprotein A-IV plot, a breakpoint of 5.95E+07 provides perfect classification of sera from ovarian cancer versus control patients.
Supporting Figure 12 : Three dimensional plot depicting the accuracy of Random Forest (RF) classification of sera from seven control and six ovarian cancer patients based on triplicate TOCPA analyses of ten biomarker proteins. The RF analyses were carried out with either 500 (blue) or 10,000 trees (red).
Supporting Figure 13 : Box plot of mean transition peak areas for TOCPA proteins. The pink (cancer) and green (control) boxes depict the first and third quartiles for each of the indicated proteins while the lines indicate the range or inner fence (when there are outliers). The inner fence is equal to 1.5x range of first and third quartiles. The pink and green dots indicate outliers while the black dot indicates the values for ovarian cancer sample R827.
Supporting Figure 14 : Trajectory of mean ApoA-IV transition peak area in technical replicates of sera from six patients with ovarian cancer as a function of disease stage. On the above graph 1 = stage IC, 2 = stage IIC, 3 = stage IIIC, 4 = stage IVC, and 5 = stage "X" which is advanced disease with disseminated carcinomatosis throughout the peritoneal cavity that cannot be removed by surgery.
